SSKN
STRATA Skin Sciences, Inc. · Healthcare
No insider bought or sold STRATA Skin Sciences, Inc. in the last 12 months
SSKN over the last year
SSKN after insider buys
3 months after each buy, from the first price a copier could get.
6 buys since 2018 with 3 months of prices.
Every filing
12 insider filings since 2016, newest first
Uri Geiger · Director and 10% owner
Accelmed Partners, L.P. · 10% owner
Dolev Rafaeli · CEO
22Nw, LP · 10% owner
Robert Joseph Moccia · CEO
Christopher Lesovitz · CFO
William D. Humphries · Director
Robert Joseph Moccia · CEO
Nachum Shamir · Director
Luann Via · Director
Samuel E Navarro · Director
Broadfin Healthcare Master Fund Ltd · 10% owner
About STRATA Skin Sciences, Inc.
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc. and changed its name to STRATA Skin Sciences, Inc. in December 2015. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.